Zhang Jie, Gu Qiang, Wu Yuan, Xie Han, Wei Cuijie, Zhang Yao, Ji Taoyun, Bao Xinhua, Chang Xingzhi, Zhang Yuehua, Jiang Yuwu, Wu Ye
Children's Medical Center, Department of Neurology, Peking University First Hospital, Beijing, China.
Epilepsia Open. 2025 Aug;10(4):1147-1160. doi: 10.1002/epi4.70077. Epub 2025 Jun 19.
To confirm the retention rate of ketogenic diet therapy (KDT) in children with drug-resistant epilepsy and identify its related factors through a cohort analysis.
This was a single-center cohort study. Baseline data were collected, and regular follow-up was conducted after KDT treatment. The retention rate of KDT at different time points was determined. Cox regression analyses and other statistical methods were used to identify the factors related to the retention rate.
A total of 337 patients were included. 43.3% (146/337) of the patients had only spasms, 16.9% (57/337) had a genetic etiology, and 14.0% (47/337) had a structural etiology. Overall, 51.9% (175/337) of the patients were classified as having infantile epileptic spasm syndrome. The median age at KDT initiation was 33 months. 38.3% (129/337) of the patients responded to KDT. The retention rate of KDT at 3, 6, 12 and 24 months were 86.6% (292/337), 62.6% (211/337), 35.0% (118/337), and 20.2% (68/337), respectively. 9.9% (56/282) stopped the treatment due to unsatisfactory seizure control and 54.6% (154/282) stopped due to a non-response. The retention rate in patients who responded to KDT was relatively greater than that in patients who did not respond to KDT [HR: 4.714 (95% CI: 3.493, 6.362), p < 0.001]. The retention rate of KDT at 3 months was associated with seizure type and anti-seizure efficacy. The retention rate of KDT at 6 months was associated with seizure type, status epilepticus and anti-seizure efficacy. The retention rate of KDT at 12 and 24 months were both associated with anti-seizure efficacy.
Anti-seizure efficacy was the sole independent predictor of long-term retention. This large-scale cohort study advances the field by demonstrating the predominant role of efficacy in long-term adherence. The cohort size (N = 337), one of the largest reported, strengthens evidence that the long-term retention rate (>1 year) can be used as an important indicator to evaluate the efficacy of KDT, which is simple and reliable.
通过队列分析确定生酮饮食疗法(KDT)在耐药性癫痫儿童中的保留率,并确定其相关因素。
这是一项单中心队列研究。收集基线数据,并在KDT治疗后进行定期随访。确定KDT在不同时间点的保留率。使用Cox回归分析和其他统计方法确定与保留率相关的因素。
共纳入337例患者。43.3%(146/337)的患者仅有痉挛发作,16.9%(57/337)有遗传病因,14.0%(47/337)有结构性病因。总体而言,51.9%(175/337)的患者被归类为婴儿痉挛症综合征。开始KDT治疗的中位年龄为33个月。38.3%(129/337)的患者对KDT有反应。KDT在3、6、12和24个月时的保留率分别为86.6%(292/337)、62.6%(211/337)、35.0%(118/337)和20.2%(68/337)。9.9%(56/282)的患者因癫痫控制不佳而停止治疗,54.6%(154/282)的患者因无反应而停止治疗。对KDT有反应的患者的保留率相对高于对KDT无反应的患者[风险比:4.714(95%置信区间:3.493,6.362),p<0.001]。KDT在3个月时的保留率与癫痫发作类型和抗癫痫疗效相关。KDT在6个月时的保留率与癫痫发作类型、癫痫持续状态和抗癫痫疗效相关。KDT在12个月和24个月时的保留率均与抗癫痫疗效相关。
抗癫痫疗效是长期保留的唯一独立预测因素。这项大规模队列研究通过证明疗效在长期依从性中的主要作用推动了该领域的发展。队列规模(N = 337)是已报道的最大规模之一,强化了长期保留率(>1年)可作为评估KDT疗效的重要指标的证据,该指标简单可靠。